Team

john-moore

John Moore

Founder and Managing Partner

After nearly 15 years in the manufacturing sector advising some of the largest global manufacturing companies on IT adoption and deployment strategies, John Moore felt that the most vexing issues in this sector had been largely addressed. He became restless and sought new opportunities with new challenges. After nearly a year of research, he chose healthcare as his next target and launched Chilmark Research in 2007.

From those humble beginnings, John has built Chilmark Research into a respected analyst firm that provides market-leading coverage of the most transformative sectors of healthcare IT, including health information exchanges, patient-provider engagement strategies, healthcare analytics, and remote monitoring. Of great personal interest to John is the role that the consumer will ultimately play in the rapidly evolving healthcare market.An accomplished speaker, John has made numerous presentations on current and future IT trends and their impact to markets. He has been widely quoted in numerous publications, including AMA News, Baseline, CIO, ComputerWorld, eWeek, Forbes, Health Data Management, InformationWeek, Investors Business Daily, US News & World Report, Washington Post and the Wall Street Journal.

brian-murphy

Brian Murphy

Analyst

HIE Strategies and Technologies

Brian Murphy joined Chilmark Research as an industry analyst in August 2012 and brings a wealth of experience to the table. In addition to being a strong advocate for the critical role that HIT can play in improving the quality of care, Brian has had direct experience as both an analyst at Yankee Group and more recently with the EHR company, Eclipsys, which was acquired by Allscripts.

Brian has worked in the IT business for over 25 years, beginning his career in the field-sales organization of IBM. As a systems engineer, Brian worked with customers across multiple industries, including several hospitals in the metro-Boston area. Brian then joined Yankee Group as an analyst, where he managed an enterprise software service and led research on the dynamics of the database market. Leaving Yankee, Brian joined Eclipsys in corporate marketing prior to its acquisition by Allscripts in 2010. While at Eclipsys, Brian worked with product managers to refine and harmonize their value propositions in light of Eclipsys’ broader goals. When not thinking about healthcare IT, Brian is a runner and armchair Boston historian.

Brian is a graduate of both Harvard College and Suffolk Law School.

naveen-rao

Naveen Rao

Analyst

Patient and Consumer Engagement Strategies and Enabling Technologies

Naveen Rao joined Chilmark Research as an industry analyst in September 2011. His research focuses on the patient engagement and mHealth markets as well as the evolving payer and regulatory environment.

Prior to joining Chilmark Research, Naveen spent three years as a quality improvement and policy strategist at the Alliance of Community Health Plans (ACHP) in Washington D.C. His responsibilities included HEDIS and CAHPS benchmarking for public and private lines of business, as well as leading a care management workgroup. Some of his clients included Geisinger Health Plan, Group Health, Kaiser Permanente, HealthPartners, UPMC Health Plan and Tufts.

Most recently, Naveen led health IT strategy at the LIVESTRONG Foundation, where he successfully oversaw the integration of a patient-facing survivorship care plan with electronic medical records and a national cancer registry, developed a prototype for data-sharing model between an iPad app and the Dana Farber Cancer Institute’s data warehouse, and led policy engagements in partnership with the Office of the National Coordinator for Health IT (ONC) and the National Cancer Institute (NCI).

In addition to this work, Naveen successfully managed the complete inpatient ONC-ATCB certification process for electronic medical record vendor, Arcron Systems, Inc. in 2011. He has also consulted with international medical travel firm HealthGlobe on patient engagement and social media strategy. He has written on healthcare for numerous organizations including the ONC, MedCityNews,HIMSS, HealthGlobe and others.

Naveen holds a certificate in Health IT from ONC, and has a master’s degree and management certificate from Johns Hopkins Bloomberg School of Public Health

john-moore-3

John Moore III

Client Research Analyst

CAS Client Research Needs and Objectives

Graduating from Vassar College in 2007, John quickly put his degree in neuroscience to work, joining the lab of Professor Rudolph Tanzi to conduct genetic research on Alzheimer’s disease at Massachusetts General Hospital. John’s next career move was to Novartis where he joined the oncology research group, identifying novel genetic targets for breast and ovarian cancer. After nearly three years of bench work, John made the switch to the business side of healthcare, working in the technology licensing office of Partners Healthcare as well as an intern for Mass Medical Angels.

This experience prompted John to found a mobile health startup, RxApps, focused on creating a longitudinal record of disease for patients living with mental illness. This team went through the Rock Health accelerator and joined the Startup Health program before putting the project on hiatus due to a number of factors (which he would be happy to discuss if you are interested).

John brings a unique background to the team, and has recently been promoted to the Director of Operations, where he oversees the publication calendar, team management and marketing efforts. He is also the primary liaison with all CAS clients, ensuring everyone gets the most from their subscriptions.

With a natural inquisitive nature combined with superb research and writing skills, John is a welcomed asset to Chilmark Research. And yes, he is the son of the founder.

matt

Matt Guldin

Analyst

Clinical Analytics and Care Coordination

Mr. Guldin brings with him a diverse array of knowledge and experience about the healthcare industry having worked in a variety capacities including pharmaceutical consulting, medical education, and academic research. Prior to working with Chilmark Research in his current role, Matt worked as an IT analyst monitoring and analyzing emerging trends, technologies, and market behavior in the Healthcare IT industry (HIT) in North America. He worked with such major industry brands as Lumeris, Thomson Reuters and Siemens. It was with the recent Cerner acquisition of Siemens that brought Matt back to the Chilmark family.

Matt is interested in how the HIT industry is gradually evolving from one that accomplished basic administrative and clinical functions to one that begins to enable more dramatic transformational change across the healthcare industry. Mr. Guldin has also held positions at the Managed Health Network (Health Net), Tufts Health Care Institute, the Boston University School of Public Health, and Metaworks, Inc. He holds a Master’s in Public Health with a concentration in Health Services from the Boston University School of Public Health and a B.A. in Biology from Boston University.

sean-campbell

Sean Campbell

Director, Business Development

Sean Campbell specializes in business development, messaging and leveraging the data in companies’ CRM systems through extensive proactive outbound work. He brings over 15 years of Inside and Field Sales Experience to the firm. Sean has been successful in building and managing inside sales and Business Development organizations at companies such as Cognos Corporation, Object Design and Dataware Technologies. He also has extensive field sales experience and has spent the last six years helping three different startup organizations establish market share and predicatable revenue streams. Sean received a BS degree in Political Science from the University of California, Berkeley. He enjoys skiing with his two children and is an avid cyclist.

Who We Are

Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary.